摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl (1'R,2'R,3'S,4'S,6'R)-8'-ethoxyspiro[1,3-dioxolane-2,5'-7,9-dioxatricyclo[4.3.0.02,4]nonane]-3'-carboxylate | 188885-77-0

中文名称
——
中文别名
——
英文名称
ethyl (1'R,2'R,3'S,4'S,6'R)-8'-ethoxyspiro[1,3-dioxolane-2,5'-7,9-dioxatricyclo[4.3.0.02,4]nonane]-3'-carboxylate
英文别名
——
ethyl (1'R,2'R,3'S,4'S,6'R)-8'-ethoxyspiro[1,3-dioxolane-2,5'-7,9-dioxatricyclo[4.3.0.02,4]nonane]-3'-carboxylate化学式
CAS
188885-77-0
化学式
C14H20O7
mdl
——
分子量
300.309
InChiKey
VWEIKSOBQZULGY-JOVKRTQCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.1
  • 重原子数:
    21
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.93
  • 拓扑面积:
    72.4
  • 氢给体数:
    0
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    ethyl (1'R,2'R,3'S,4'S,6'R)-8'-ethoxyspiro[1,3-dioxolane-2,5'-7,9-dioxatricyclo[4.3.0.02,4]nonane]-3'-carboxylate 以50%的产率得到ethyl (1R,5S,6S)-4-oxobicyclo[3.1.0]hex-2-ene-6-carboxylate
    参考文献:
    名称:
    Asymmetric synthesis of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740)
    摘要:
    The asymmetric synthesis of(+)-2-aminobicyclo[3.1.0]hexane-2, 6-dicarboxylic acid (LY354740) 1, a potent and selective group 2 mGluR agonist, has been accomplished starting from the readily available enantiomerically pure cyclopentenone 4. Thus, cyclopropanation with ethyl(dimethylsulfuranylidene)acetate generated in situ with DBU, followed by deketalization gave rise to the dihydroxy bicyclic ketone 9. After protecting the ketone as 1,3-dioxolane and its transformation to the orthoformate 11, this was pyrolytically deoxygenated in a sealed tube to the bicyclic enone 13. The Synthesis was completed after hydrogenation, stereoselective Bucherer-Bergs reaction and hydantoin hydrolysis, yielding LY354740 (+)-1 with an e.e. greater than or equal to 98%. (C) 1997 Elsevier Science Ltd. rights reserved.
    DOI:
    10.1016/s0957-4166(97)00001-3
  • 作为产物:
    参考文献:
    名称:
    Asymmetric synthesis of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740)
    摘要:
    The asymmetric synthesis of(+)-2-aminobicyclo[3.1.0]hexane-2, 6-dicarboxylic acid (LY354740) 1, a potent and selective group 2 mGluR agonist, has been accomplished starting from the readily available enantiomerically pure cyclopentenone 4. Thus, cyclopropanation with ethyl(dimethylsulfuranylidene)acetate generated in situ with DBU, followed by deketalization gave rise to the dihydroxy bicyclic ketone 9. After protecting the ketone as 1,3-dioxolane and its transformation to the orthoformate 11, this was pyrolytically deoxygenated in a sealed tube to the bicyclic enone 13. The Synthesis was completed after hydrogenation, stereoselective Bucherer-Bergs reaction and hydantoin hydrolysis, yielding LY354740 (+)-1 with an e.e. greater than or equal to 98%. (C) 1997 Elsevier Science Ltd. rights reserved.
    DOI:
    10.1016/s0957-4166(97)00001-3
点击查看最新优质反应信息

文献信息

  • Asymmetric synthesis of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740)
    作者:Carmen Domínguez、Jesús Ezquerra、Lourdes Prieto、Modesta Espada、Carmen Pedregal
    DOI:10.1016/s0957-4166(97)00001-3
    日期:1997.2
    The asymmetric synthesis of(+)-2-aminobicyclo[3.1.0]hexane-2, 6-dicarboxylic acid (LY354740) 1, a potent and selective group 2 mGluR agonist, has been accomplished starting from the readily available enantiomerically pure cyclopentenone 4. Thus, cyclopropanation with ethyl(dimethylsulfuranylidene)acetate generated in situ with DBU, followed by deketalization gave rise to the dihydroxy bicyclic ketone 9. After protecting the ketone as 1,3-dioxolane and its transformation to the orthoformate 11, this was pyrolytically deoxygenated in a sealed tube to the bicyclic enone 13. The Synthesis was completed after hydrogenation, stereoselective Bucherer-Bergs reaction and hydantoin hydrolysis, yielding LY354740 (+)-1 with an e.e. greater than or equal to 98%. (C) 1997 Elsevier Science Ltd. rights reserved.
查看更多